Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.
LEUKEMIA & LYMPHOMA(2010)
Abstract
In recent years, knowledge about the role of the JAK2 V617F somatic mutation in the pathogenesis of bcr/abl negative myeloproliferative neoplasms (MPNs) has led to consideration of the mutational s...
MoreTranslated text
Key words
myelodysplastic syndrome,mutation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined